Helle K M Bergholdt1, Børge G Nordestgaard2, Anette Varbo1, Christina Ellervik3. 1. Department of Clinical Biochemistry, Naestved Hospital, Denmark, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark, Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen, Denmark, Department of Research, Nykoebing Falster Hospital, Nykoebing Falster, Denmark and Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA Department of Clinical Biochemistry, Naestved Hospital, Denmark, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark, Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen, Denmark, Department of Research, Nykoebing Falster Hospital, Nykoebing Falster, Denmark and Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA. 2. Department of Clinical Biochemistry, Naestved Hospital, Denmark, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark, Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen, Denmark, Department of Research, Nykoebing Falster Hospital, Nykoebing Falster, Denmark and Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA Department of Clinical Biochemistry, Naestved Hospital, Denmark, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark, Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen, Denmark, Department of Research, Nykoebing Falster Hospital, Nykoebing Falster, Denmark and Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA Department of Clinical Biochemistry, Naestved Hospital, Denmark, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark, Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen, Denmark, Department of Research, Nykoebing Falster Hospital, Nykoebing Falster, Denmark and Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA. 3. Department of Clinical Biochemistry, Naestved Hospital, Denmark, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark, Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen, Denmark, Department of Research, Nykoebing Falster Hospital, Nykoebing Falster, Denmark and Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA Department of Clinical Biochemistry, Naestved Hospital, Denmark, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark, Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen, Denmark, Department of Research, Nykoebing Falster Hospital, Nykoebing Falster, Denmark and Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA Department of Clinical Biochemistry, Naestved Hospital, Denmark, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark, Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen, Denmark, Department of Research, Nykoebing Falster Hospital, Nykoebing Falster, Denmark and Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA christina@ellervik.dk.
Abstract
BACKGROUND: Observationally, reports on the association between milk intake and risk of ischaemic heart disease (IHD) and myocardial infarction (MI) have produced conflicting results; and no previous large-scale study using the lactase persistent/non-persistent LCT-13910 C/T genotype as a largely unconfounded proxy for milk intake free of reverse causation has been conducted. We tested the hypothesis that milk intake observationally and genetically through the LCT-13910 C/T genotype is associated with risk of IHD and MI in a Mendelian randomization design. METHODS: We included 98,529 White individuals of Danish descent, aged 20-100 years, from three studies of the general population. Information on IHD (N = 10,372) and MI (N = 4188) were obtained from national Danish registries. First, we investigated observational associations between milk intake and incident IHD and MI. Second, we confirmed the association between the rs4988235 genetic variant LCT-13910 C/T, associated with lactase persistence/non-persistence, and milk intake. Finally, we tested whether LCT-13910 C/T genotype was associated with risk of IHD and MI as well as with cardiovascular risk factors. RESULTS: During a mean follow-up time of 5.4 years, the observational hazard ratio for a 1 glass/week higher milk intake was 1.00 [95% confidence interval (CI): 1.00,1.01] for both IHD and MI. Median milk intake was 3 glasses/week (interquartile range: 0-7) in lactase CC non-persistent individuals compared with 5 glasses/week (0-10) in lactase TC/TT persistent individuals (P = 3*10(-60)). In the dominant genetic model comparing lactase TC/TT persistent individuals with lactase CC non-persistent individuals, the odds ratio was 1.00 (0.92,1.09) for IHD and 0.96 (0.84,1.09) for MI. Finally, in the dominant genetic model genotype was not associated convincingly with plasma levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides or glucose, nor with blood pressure. CONCLUSION: Milk intake was not associated with risk of IHD or MI, observationally or genetically.
BACKGROUND: Observationally, reports on the association between milk intake and risk of ischaemic heart disease (IHD) and myocardial infarction (MI) have produced conflicting results; and no previous large-scale study using the lactase persistent/non-persistent LCT-13910 C/T genotype as a largely unconfounded proxy for milk intake free of reverse causation has been conducted. We tested the hypothesis that milk intake observationally and genetically through the LCT-13910 C/T genotype is associated with risk of IHD and MI in a Mendelian randomization design. METHODS: We included 98,529 White individuals of Danish descent, aged 20-100 years, from three studies of the general population. Information on IHD (N = 10,372) and MI (N = 4188) were obtained from national Danish registries. First, we investigated observational associations between milk intake and incident IHD and MI. Second, we confirmed the association between the rs4988235 genetic variant LCT-13910 C/T, associated with lactase persistence/non-persistence, and milk intake. Finally, we tested whether LCT-13910 C/T genotype was associated with risk of IHD and MI as well as with cardiovascular risk factors. RESULTS: During a mean follow-up time of 5.4 years, the observational hazard ratio for a 1 glass/week higher milk intake was 1.00 [95% confidence interval (CI): 1.00,1.01] for both IHD and MI. Median milk intake was 3 glasses/week (interquartile range: 0-7) in lactase CC non-persistent individuals compared with 5 glasses/week (0-10) in lactase TC/TT persistent individuals (P = 3*10(-60)). In the dominant genetic model comparing lactase TC/TT persistent individuals with lactase CC non-persistent individuals, the odds ratio was 1.00 (0.92,1.09) for IHD and 0.96 (0.84,1.09) for MI. Finally, in the dominant genetic model genotype was not associated convincingly with plasma levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides or glucose, nor with blood pressure. CONCLUSION: Milk intake was not associated with risk of IHD or MI, observationally or genetically.
Authors: Richard P Evershed; George Davey Smith; Mélanie Roffet-Salque; Adrian Timpson; Yoan Diekmann; Matthew S Lyon; Lucy J E Cramp; Emmanuelle Casanova; Jessica Smyth; Helen L Whelton; Julie Dunne; Veronika Brychova; Lucija Šoberl; Pascale Gerbault; Rosalind E Gillis; Volker Heyd; Emily Johnson; Iain Kendall; Katie Manning; Arkadiusz Marciniak; Alan K Outram; Jean-Denis Vigne; Stephen Shennan; Andrew Bevan; Sue Colledge; Lyndsay Allason-Jones; Luc Amkreutz; Alexandra Anders; Rose-Marie Arbogast; Adrian Bălăşescu; Eszter Bánffy; Alistair Barclay; Anja Behrens; Peter Bogucki; Ángel Carrancho Alonso; José Miguel Carretero; Nigel Cavanagh; Erich Claßen; Hipolito Collado Giraldo; Matthias Conrad; Piroska Csengeri; Lech Czerniak; Maciej Dębiec; Anthony Denaire; László Domboróczki; Christina Donald; Julia Ebert; Christopher Evans; Marta Francés-Negro; Detlef Gronenborn; Fabian Haack; Matthias Halle; Caroline Hamon; Roman Hülshoff; Michael Ilett; Eneko Iriarte; János Jakucs; Christian Jeunesse; Melanie Johnson; Andy M Jones; Necmi Karul; Dmytro Kiosak; Nadezhda Kotova; Rüdiger Krause; Saskia Kretschmer; Marta Krüger; Philippe Lefranc; Olivia Lelong; Eva Lenneis; Andrey Logvin; Friedrich Lüth; Tibor Marton; Jane Marley; Richard Mortimer; Luiz Oosterbeek; Krisztián Oross; Juraj Pavúk; Joachim Pechtl; Pierre Pétrequin; Joshua Pollard; Richard Pollard; Dominic Powlesland; Joanna Pyzel; Pál Raczky; Andrew Richardson; Peter Rowe; Stephen Rowland; Ian Rowlandson; Thomas Saile; Katalin Sebők; Wolfram Schier; Germo Schmalfuß; Svetlana Sharapova; Helen Sharp; Alison Sheridan; Irina Shevnina; Iwona Sobkowiak-Tabaka; Peter Stadler; Harald Stäuble; Astrid Stobbe; Darko Stojanovski; Nenad Tasić; Ivo van Wijk; Ivana Vostrovská; Jasna Vuković; Sabine Wolfram; Andrea Zeeb-Lanz; Mark G Thomas Journal: Nature Date: 2022-07-27 Impact factor: 69.504
Authors: Esther Cruijsen; Maria G Jacobo Cejudo; Leanne K Küpers; Maria C Busstra; Johanna M Geleijnse Journal: Am J Clin Nutr Date: 2021-07-01 Impact factor: 7.045
Authors: Caren E Smith; Oscar Coltell; Jose V Sorlí; Ramón Estruch; Miguel Ángel Martínez-González; Jordi Salas-Salvadó; Montserrat Fitó; Fernando Arós; Hassan S Dashti; Chao Q Lai; Leticia Miró; Lluís Serra-Majem; Enrique Gómez-Gracia; Miquel Fiol; Emilio Ros; Stella Aslibekyan; Bertha Hidalgo; Marian L Neuhouser; Chongzhi Di; Katherine L Tucker; Donna K Arnett; José M Ordovás; Dolores Corella Journal: Sci Rep Date: 2016-09-14 Impact factor: 4.379